LEUKEMIA, MYELOID
Clinical trials for LEUKEMIA, MYELOID explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia: experimental combo enters human testing
Disease control Recruiting nowThis early-stage study tests the safety of a new drug called ziftomenib when combined with standard chemotherapy for people whose acute myeloid leukemia (AML) has returned or not responded to treatment. The study includes adults with specific genetic changes (NPM1 mutation or KMT…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
Supercharged immune cells aim to stop cancer return after transplant
Disease control Recruiting nowThis early-phase trial tests whether specially trained natural killer (NK) cells can safely prevent blood cancers like leukemia from coming back after a stem cell transplant. About 15 adults with high-risk disease will receive an infusion of these cells plus a supportive drug. Th…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
Immune cell boost shows promise in early leukemia trial
Disease control Recruiting nowThis early-phase study tests the safety of giving special immune cells (CIML NK cells) along with a standard drug (venetoclax) to adults with acute myeloid leukemia (AML) whose disease has come back or is hard to treat. Ten participants will receive the cell infusion after a shor…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New combo strategy aims to deepen remission in CML
Disease control Recruiting nowThis study tests a new drug, asciminib, as the first treatment for adults newly diagnosed with chronic myeloid leukemia (CML). If the drug alone doesn't work well enough after 2-3 years, a low dose of another standard drug is added. The goal is to see if this approach can achieve…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE2 • Sponsor: Augusta University • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New pill shows promise for Tough-to-Treat leukemia
Disease control Recruiting nowThis early-stage trial tests a new daily pill, BH-30236, for adults with acute myeloid leukemia (AML) or a high-risk pre-leukemia condition (MDS) that has returned or not responded to prior treatments. The study will first find the safest dose, then test it alone or with another …
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:39 UTC